Detalhe da pesquisa
1.
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Allergy
; 77(3): 897-906, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460948
2.
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
Br J Dermatol
; 187(4): 539-547, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656793
3.
Implementing an Evidence-Based Feeding Protocol: Impact on Nurses' Knowledge, Perceptions, and Feeding Culture in the NICU.
Adv Neonatal Care
; 22(6): 493-502, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596085
4.
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.
J Allergy Clin Immunol
; 147(6): 2213-2224, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33548397
5.
An Infant With Esophageal Atresia and Tracheoesophageal Fistula: What Does the X-Ray Reveal?
Neonatal Netw
; 41(4): 236-242, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840330
6.
Basic Approach to Reading a Radiograph in the Neonate.
Neonatal Netw
; 40(1): 31-37, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479009
7.
Effects of COVID-19 on Health Care Workers.
Neonatal Netw
; 40(3): 134-139, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088858
8.
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study.
J Am Acad Dermatol
; 83(5): 1341-1348, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416208
9.
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
J Allergy Clin Immunol
; 143(1): 142-154, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30121291
10.
Multiple Aplasia Cutis Congenita Lesions of the Scalp: A Case Study.
Neonatal Netw
; 39(2): 83-91, 2020 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317338
11.
Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.
Exp Dermatol
; 28(1): 35-44, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326165
12.
A Case Study of Severe Hypercalcemia Secondary to Subcutaneous Fat Necrosis: A Diagnosis of Exclusion.
Neonatal Netw
; 38(4): 236-241, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470393
13.
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.
J Am Acad Dermatol
; 78(5): 872-881.e6, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353025
14.
Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans.
Exp Dermatol
; 26(8): 721-727, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27943413
15.
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.
Exp Dermatol
; 26(1): 28-35, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27304428
16.
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis.
J Allergy Clin Immunol
; 138(1): 169-178, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26948076
17.
Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer.
J Allergy Clin Immunol
; 137(4): 1091-1102.e7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26431582
18.
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
J Allergy Clin Immunol
; 136(1): 104-115.e7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25748064
19.
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.
J Allergy Clin Immunol
; 133(6): 1626-34, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24786238
20.
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.
J Allergy Clin Immunol
; 128(3): 583-93.e1-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21762976